Elective Neck Dissection in cT1‐4 N0M0 Head and Neck Basaloid Carcinoma
Otolaryngology–Head and Neck Surgery · 2024-08 · 171 (2) · 457-470
DOI: 10.1002/ohn.757 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 12.04.2024. Verfasst von Aman M Patel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA. Hauptthemen laut MEDLINE: Neck Dissection, Elective Surgical Procedures, Head and Neck Neoplasms, Neoplasm Staging. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To investigate the survival benefit of elective neck dissection (END) over neck observation in surgically resected cT1‐4 N0M0 head and neck basaloid carcinoma (HNBC). Study Design Retrospective cohort study.
Setting
The 2006 to 2017 hospital‐based National Cancer Database.
Methods
Patients with surgically resected cT1‐4 N0M0 HNBC were selected. Linear, binary logistic, Kaplan‐Meier, and Cox proportional hazards regression models were implemented.
Results
Of 857 patients satisfying inclusion criteria, the majority were male (77.0%) and white (88.1%) with disease of the oral cavity (21.5%) or oropharynx (42.9%) classified as high grade (76.9%) and cT1‐2 (72.9%). 389 (45.4%) patients underwent END. END utilization between 2006 and 2017 increased for cT1‐2 disease (33.3% vs 56.9%, R 2 = .699) but remained relatively constant for cT3‐4 disease (66.7% vs 57.9%, R 2 = .062). One‐hundred and fifteen (29.6%) ENDs detected occult nodal metastases (ONMs). The 5‐year overall survival (OS) of patients undergoing neck observation and END was 65.6% and 66.8%, respectively ( P = .652). END was not associated with improved OS in survival analyses stratified by patient demographics, clinicopathologic features, and adjuvant therapy. Compared with surgery alone, adjuvant radiotherapy (adjusted hazard ratio: 0.74, 95% confidence interval [CI]: 0.57‐0.97, P = .031) was associated with improved OS. END (hazard ratio [HR]: 0.96, 95% CI: 0.71‐1.28, P = .770) and ONM (HR: 1.12, 95% CI: 0.78‐1.61, P = .551) were not associated with OS.
Conclusion
END is performed in nearly half of patients with HNBC but is not associated with improved OS, even after stratifying survival analyses by patient demographics, clinicopathologic features, and adjuvant therapy. The rate of ONM approaching 30%, however, justifies inclusion of END in the surgical management of HNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
- Department of Otorhinolaryngology-Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Otolaryngology, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Aman M Patel, Afash Haleem, Hassaam S Choudhry, Robert M Brody, Jason A Brant, Ryan M Carey
Zitieren
APA
Patel, A. M., Haleem, A., Choudhry, H. S., Brody, R. M., Brant, J. A., & Carey, R. M. (2024). Elective Neck Dissection in cT1‐4 N0M0 Head and Neck Basaloid Carcinoma. Otolaryngology–Head and Neck Surgery, 171(2), 457-470. https://doi.org/10.1002/ohn.757
Vancouver
Patel AM, Haleem A, Choudhry HS, Brody RM, Brant JA, Carey RM. Elective Neck Dissection in cT1‐4 N0M0 Head and Neck Basaloid Carcinoma. Otolaryngology–Head and Neck Surgery. 2024;171(2):457-470. doi:10.1002/ohn.757
BibTeX
@article{Patel2024,
author = {Patel, Aman M and Haleem, Afash and Choudhry, Hassaam S and Brody, Robert M and Brant, Jason A and Carey, Ryan M},
title = {Elective Neck Dissection in cT1‐4 N0M0 Head and Neck Basaloid Carcinoma},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2024},
volume = {171},
number = {2},
pages = {457--470},
doi = {10.1002/ohn.757}
}
EUVIMED